Francisco Javier
López González
Hospital Universitario de Valladolid
Valladolid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Valladolid (7)
2020
-
Observational multicentre study into the use of antiepileptic drugs in Spanish neurology consultations
Neurologia, Vol. 35, Núm. 2, pp. 115-125
2019
-
Clinical outcomes of eslicarbazepine acetate monotherapy for focal-onset seizures: A multicenter audit
Acta Neurologica Scandinavica, Vol. 140, Núm. 6, pp. 422-428
2018
-
Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study
Epilepsia, Vol. 59, Núm. 9, pp. 1740-1752
2017
-
EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure
Acta Neurologica Scandinavica, Vol. 136, Núm. 3, pp. 254-264
-
Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. (2016) 126 (201–210)] (S0920121116301218)(10.1016/j.eplepsyres.2016.08.001)
Epilepsy Research
2016
-
Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study
Epilepsy Research, Vol. 126, pp. 201-210
2015
-
Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study
Clinical Drug Investigation, Vol. 35, Núm. 2, pp. 121-131